Launch of a pioneering clinical trial to validate the efficacy of immunotherapy in 29 types of tumour

The ACROPOLI clinical trial is being launched. It is a pioneering, nationwide research study that aims to assess the efficacy of immunotherapy in 29 different types of cancer simultaneously. This is the first basket trial –that measures the clinical use of a single drug in different tumours sharing a common biomarker– promoted by the SOLTI academic cooperative research group. More specifically, the trial will assess the predictive value of the molecular biomarker PD-1.

A total of 141 patients and 10 Spanish hospitals